California State Teachers Retirement System Cti Biopharma Corp Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023
BUY
$4.2 - $6.01 $29,181 - $41,757
6,948 Added 5.82%
126,408 $530,000
Q4 2022

Feb 14, 2023
BUY
$4.45 - $6.17 $355,715 - $493,205
79,936 Added 202.25%
119,460 $717,000
Q3 2022

Nov 18, 2022
SELL
$5.36 - $7.43 $460 - $638
-86 Reduced 0.22%
39,524 $230,000
Q2 2022

Aug 15, 2022
BUY
$3.55 - $6.27 $140,615 - $248,354
39,610 New
39,610 $236,000
Q2 2019

Aug 14, 2019
SELL
$0.8 - $1.03 $62,541 - $80,522
-78,177 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$3.81 - $5.26 $297,854 - $411,211
78,177 New
78,177 $389,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email